US stocks fall in volatile trade as investors weigh cooler job gains against high wage growth
US stocks finished lower on Friday amid volatile trade and capped weekly losses as Wall Street digested the latest jobs report.
The Labor Department reported 209,000 new jobs were created, below expectations, after ADP's payroll report Thursday showed blowout gains. However, the government's report Friday also found that wage growth saw a 4.4% jump on an annual basis, which could prompt the central bank to continue lifting interest rates to rein in inflation.
Stocks seesawed between losses and gains over the course of the day before closing lower. For the week, the S&P 500 lost 1.16%, the Nasdaq declined 0.92%, and the Dow sank 1.96%.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Affirm's stock dives after analyst gives reasons investors should sellAffirm's stock fell Thursday after Piper recommended investors sell, as higher rates and competition hurt revenue and lead to margin contraction.
Read more »
Retail investors keep chasing the stock market rally, rotating to EVs from AI: analystsIndividual investors keep chasing a 2023 stock-market rally, but show signs of pivoting toward electric-vehicle makers and away from AI plays, research firm...
Read more »
'Complacent' stock market investors start to 'respect' higher-for-longer U.S. interest ratesFinancial markets finally come around to idea that U.S. interest rates are likely to stay higher for longer, driven by a blowout private-sector jobs report.
Read more »
Stock futures inch downward as investors look toward Friday jobs report: Live updatesInvestors eyed the forthcoming non-farm payroll report from the Labor Department on Friday.
Read more »
Retail investors are aggressively chasing the stock market rally in AI, EVsRetail investors are chasing the rally in the stock market. Here's exactly what they're buying.
Read more »
Caribou Biosciences stock soars after Pfizer buys stock priced at a 31% premiumShares of Caribou Biosciences Inc. ran up 21.3% toward a three-month high in premarket trading Thursday, after the genome-editing biopharmaceutical company...
Read more »